A Study in Participants With Acute Leukemia
NCT01214603
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Leukemia
Interventions
DRUG:
LY2090314
Sponsor
Eli Lilly and Company